English

More about this topic

Health news

New Alzheimer’s drug gets full approval from US regulators

The treatment received conditional approval in January, but received full approval following a review of data from a further 1,800 patient study that showed the drug slowed cognitive decline by 5 months.

Health news

Move over, CBD: HHC is the new ‘legal cannabis’ causing concern

After the boom of CBD, authorities worry about HHC, which can be ingested, smoked or vaped, with effects similar to those of cannabis.

Healthcare

Recreational cannabis goes on sale in some Swiss pharmacies

A new pilot aims to assess the health effects of regulating cannabis supply in the Swiss city of Basel - and soon in Zurich, Geneva, and Lausanne.

Health news

Biden urges drug giants to slash insulin prices after Eli Lilly’s move

"It’s a big deal, and it’s time for other manufacturers to follow," the US president said.

ADVERTISEMENT

Health news

Cannabis start-ups blooming as Germany eyes legal recreational use

German start-ups growing cannabis for medical use - legal in the country since 2016 - are booming. What impact will a move to recreational use have?

Health news

Can AI help detect the early stages of Alzheimer’s?

The NHS is trialling a new AI-assisted tool that could help to diagnose mild cognitive impairment, a precursor to Alzheimer’s.

USA

Bayer to pay $10.9 billion to settle weedkiller cancer lawsuits

German chemical giant Bayer said Wednesday it would pay up to $10.9 billion (9.6 billion euros) to settle a wave of lawsuits from Americans who allege its Roundup weedkiller caused their cancers.

World News

Early COVID-19 drug treatment trial shows promise, needs more study

More than half of 53 severely ill COVID-19 patients treated with remdesivir showed improvement, but further information needed to determine its potential, experts say.

World News

Drugmaker launches lottery for life-saving gene therapy in babies

Swiss drugmaker Novartis has launched an international lottery for its groundbreaking and extremely costly gene therapy Zolgensma, sparking both hope and outrage among patients’ families.

USA

Drug companies reach 11th-hour deal to settle US opioids lawsuit

The US three dominant drug distributors and a big drugmaker reached a last-minute deal to settle a lawsuit over the opioid crisis just at the first federal trial was about to start.

Hungary

Hungarians raise €2m for sick toddler to access world's priciest drug

People in Hungary have raised €2m for the family of a toddler with a rare genetic disorder to access the world’s most expensive drug

France

Mediator: Landmark trial opens in France over antidiabetic pill

Servier Laboratories, the National Agency for the Safety of Medicines (ANSM) and 21 other defendants will face 2,684 plaintiffs. They allege that Mediator, marketed as an antidiabetic drug, has cost the lives of hundreds of patients.